GENNEX LABORATORIES LTD. - Board Meeting Outcome for Outcome Of The Board Meeting Held On 27 January, 2024 Of Gennex Laboratories Limited - BSE Script Code: 531739
Download 
|
< Back |
| 27 Jan 2024 | |
| Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 read with Schedule III thereto, and in furtherance to our intimation dated 20/11/2023, 29/11/2023, and Board meeting outcome filed on 02/12/2023, we wish to inform you that Board of Directors of the Company, at its meeting held today, on 27/01/2024 has considered and approved the following: 1. Allotment of 5,00,00,000 equity shares of the Company having face value of Re. 1/- each at a price of Rs. 14.75/- aggregating to Rs. 73,75,00,000 on preferential basis to specified persons. 2. Allotment of 1,55,00,000 share warrants of the Company at a price of Rs. 14.75 each (warrant subscription price Rs. 3.69/- and the warrant exercise price Rs. 11.06/- per warrant) aggregating to Rs. 22,86,25,000 to the member of promoter group on a preferential basis The meeting commenced at 2.00 PM and concluded at 2.30 PM. We request you to take the above information on record and acknowledge receipt of the same. | |
| View all announcements for GENNEX LABORATORIES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback